Dr Gnant - ESMO Oral Presentation 08
Dr Gnant - ESMO Oral Presentation 08
Dr Gnant - ESMO Oral Presentation 08
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Study Endpoints (TAM vs ANA; ZOL vs No ZOL)<br />
• Primary endpoint<br />
– Disease-free survival (DFS)<br />
– DFS events: local recurrence, contralateral breast cancer,<br />
distant metastasis, secondary carcinoma, death<br />
• Secondary endpoints<br />
– Recurrence-free survival (RFS): local recurrence,<br />
contralateral breast cancer, distant metastasis,<br />
secondary carcinoma<br />
– Overall survival<br />
– Safety<br />
• Exploratory endpoint<br />
– Bone-metastases–free survival<br />
6
Change language